Skip to main content
Breelyn Wilky, MD, Oncology, Aurora, CO

BreelynAnnWilkyMD

Oncology Aurora, CO

Hematologic Oncology, Sarcoma

Assistant Professor, Sarcoma Program

Dr. Wilky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wilky's full profile

Already have an account?

  • Office

    12401 E 17th Ave
    Aurora, CO 80045
    Phone+1 720-848-4289
    Fax+1 720-848-4293

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2006 - 2009
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 2006

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2018 - 2025
  • FL State Medical License
    FL State Medical License 2013 - 2019
  • MD State Medical License
    MD State Medical License 2009 - 2013
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Young Investigator Award ASCO/Conquer Cancer Foundation, 2012
  • Alpha Omega Alpha, Medical Honor Society 2004
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Phase I open-label, ascending dose trial of AGEN1884, an anti-CTLA-4 monoclonal antibody, in advanced solid malignancies: Dose selection for combination with PD-1 bloc... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
  • A phase II trial of axitinib plus pembrolizumab for patients with advanced alveolar soft part sarcoma (ASPS) and other soft tissue sarcomas (STS). 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Agenus (AGEN) Q1 2023 Earnings Call Transcript
    Agenus (AGEN) Q1 2023 Earnings Call TranscriptMay 9th, 2023
  • Agenus Inc (AGEN) Q2 2020 Earnings Call Transcript
    Agenus Inc (AGEN) Q2 2020 Earnings Call TranscriptAugust 6th, 2020
  • Deciphera Pharmaceuticals, Inc. To Present Data from DCC-3014 and Ripretinib Programs at the Connective Tissue Oncology Society (CTOS) 2019 Annual Meeting
    Deciphera Pharmaceuticals, Inc. To Present Data from DCC-3014 and Ripretinib Programs at the Connective Tissue Oncology Society (CTOS) 2019 Annual MeetingNovember 13th, 2019
  • Join now to see all

Professional Memberships